Data gathered: December 24
AI Stock Analysis - Zimmer Biomet (ZBH)
Analysis generated July 23, 2024. Powered by Chat GPT.
Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in the design, manufacture, and distribution of various orthopedic and musculoskeletal products. Their portfolio includes joint replacement products, surgical tools, and spine, sports medicine, and trauma solutions. As a pioneer in the orthopedic industry, Zimmer Biomet is well-positioned to capitalize on the growing demand for innovative healthcare solutions driven by an aging population and increased incidence of musculoskeletal disorders.
Stock Alerts - Zimmer Biomet (ZBH)
 |
Zimmer Biomet | December 11 Job postings are down by 17.5% in the last couple of days. |
|
Zimmer Biomet | December 9 Ro Khanna (member of U.S. congress) is buying shares |
|
Zimmer Biomet | December 7 Job postings are down by 22.4% in the last couple of days. |
|
Zimmer Biomet | December 1 Job postings are down by 18.8% in the last couple of days. |
Alternative Data for Zimmer Biomet
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 312 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 274,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 27 | Sign up | Sign up | Sign up |
| Patents | 430 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 29 | Sign up | Sign up | Sign up |
| Facebook Followers | 34,548 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,239 | Sign up | Sign up | Sign up |
| Twitter Followers | 11,571 | Sign up | Sign up | Sign up |
| Twitter Mentions | 7 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,220 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 54 | Sign up | Sign up | Sign up |
| Linkedin Employees | 17,673 | Sign up | Sign up | Sign up |
About Zimmer Biomet
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
| Price | $106.82 |
| Target Price | Sign up |
| Volume | 1,860,000 |
| Market Cap | $21.3B |
| Year Range | $101.77 - $121.17 |
| Dividend Yield | 0.9% |
| PE Ratio | 20.44 |
| Analyst Rating | 33% buy |
| Industry | Medical Devices |
In the news
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 22 - Finnhub |
|
 |
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $118.00 at Truist FinancialDecember 20 - ETF Daily News |
 |
Zimmer Biomet price target raised to $118 from $117 at TruistDecember 18 - Yahoo |
 |
Zimmer Biomet price target raised by $1 at Truist, here's whyDecember 18 - Thefly.com |
 |
Zimmer Biomet sets quarterly dividend for Q4 2024December 18 - Investing.com |
 |
Wellington Management Group LLP Raises Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)December 18 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.78B | 1.4B | 380M | 249M | 428M | 1.740 |
| Q2 '24 | 1.88B | 1.43B | 444M | 243M | 495M | 2.010 |
| Q1 '24 | 1.83B | 1.39B | 436M | 172M | 408M | 1.940 |
| Q4 '23 | 1.89B | 1.8B | 95M | 419M | 889M | 2.200 |
| Q3 '23 | 1.69B | 1.34B | 355M | 163M | 412M | 1.650 |
Insider Transactions View All
| Yi Sang filed to sell 5,322 shares at $114.7. June 4 '24 |
| Yi Sang filed to sell 18,179 shares at $126.9. March 8 '24 |
| Phipps Chad F filed to sell 44,145 shares at $129.1. February 26 '24 |
| Phipps Chad F filed to sell 44,755 shares at $128.6. February 26 '24 |
| Jafry Syed A. filed to buy 4,060 shares at $104.8. November 13 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$89.86 0% | 48 |
 |
Edwards LifesciencesEW |
$74.81 0% | 33 |
 |
Intuitive SurgicalISRG |
$527.22 0% | 74 |
 |
MedtronicMDT |
$81.4 0% | 54 |
 |
StrykerSYK |
$366.49 0% | 50 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
| Ro Khanna |
Nov 11, 24 | Buy | $1K - $15K |
| Ro Khanna |
Jul 8, 24 | Buy | $1K - $15K |
Read more about Zimmer Biomet (ZBH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Zimmer Biomet?
The Market Cap of Zimmer Biomet is $21.3B.
What is Zimmer Biomet's PE Ratio?
As of today, Zimmer Biomet's PE (Price to Earnings) ratio is 20.44.
What is the current stock price of Zimmer Biomet?
Currently, the price of one share of Zimmer Biomet stock is $106.82.
How can I analyze the ZBH stock price chart for investment decisions?
The ZBH stock price chart above provides a comprehensive visual representation of Zimmer Biomet's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zimmer Biomet shares. Our platform offers an up-to-date ZBH stock price chart, along with technical data analysis and alternative data insights.
Does ZBH offer dividends to its shareholders?
Yes, Zimmer Biomet (ZBH) offers dividends to its shareholders, with a dividend yield of 0.9%. This dividend yield represents Zimmer Biomet's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Zimmer Biomet in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Zimmer Biomet?
Some of the similar stocks of Zimmer Biomet are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.